Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

26.32 +1.33 (+5.32%)
Official Closing Price Updated: 4:10 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
News headline image
Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied ↗
Novo Nordisk stock jumped Wednesday on a lighter-than-feared discount for Ozempic and Wegovy under the IRA. 
Via Investor's Business Daily
Topics Economy Government
News headline image
Jury Convicts Done Global Founder In Adderall Distribution Scheme: WSJ Report ↗
Jury convicts Done Global founder Ruthia He and former top doctor David Brody in a federal case alleging illegal Adderall distribution through the telehealth platform. 
Via Benzinga
Topics Law Enforcement
News headline image
Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗
Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven asset allocation. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More ↗
Via Stocktwits
News headline image
Billionaire Stanley Druckenmiller Sold His Fund's Entire Stakes in Nvidia and Palantir for a Scorching-Hot Drug Stock That's Up 218% Since Mid-2023 ↗
Duquesne Family Office's billionaire boss has gone full contrarian by selling Wall Street's two artificial intelligence (AI) darlings and piling into a previously struggling pharmaceutical stock. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Here's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Price Over Earnings Overview: Teva Pharmaceutical Indus ↗
 
Via Benzinga
News headline image
Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio? ↗
Expedia, SanDisk, and Penumbra led last week's large-cap gainers, with strong earnings and raised guidance fueling broad double-digit jumps. 
Via Benzinga
News headline image
Why Teva Pharmaceutical Stock Rocked the Market Today ↗
The company delivered a convincing pair of beats in its third-quarter earnings report. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook ↗
Teva Q3 revenue rose to $4.48 billion, beating estimates, as Austedo and Ajovy boosted growth; 2025 EPS outlook now $2.55–$2.65. 
Via Benzinga
News headline image
Market Movers: Eli Lilly, Cadre, BP, Kellanova, and Teva Soar to 52-Week Highs Amidst Shifting Economic Tides
In a period marked by cautious optimism and strategic pivots, several prominent companies across diverse sectors have recently defied broader economic uncertainties to achieve significant 52-week... 
Via MarketMinute
Topics Economy Intellectual Property Supply Chain
News headline image
Teva Pharma Surges On Its Big Sales Beat, Austedo Guidance Hike ↗
Teva stock jumped Wednesday on better-than-expected quarterly metrics. 
Via Investor's Business Daily
Topics Earnings
News headline image
Here's Why This Israeli Investment Giant Is Betting $834 Million on Teva Stock ↗
Here's Why This Israeli Investment Giant Is Betting $834 Million on Teva Stock 
Via The Motley Fool
Topics ETFs Economy Regulatory Compliance
News headline image
Israel’s Phoenix Financial Exits $169 Million Tower Semiconductor Stake After Stock's 99% Rally ↗
Israel’s Phoenix Financial Exits $169 Million Tower Semiconductor Stake After Stock's 99% Rally 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Harel Bets Big on Teva Pharmaceutical by Purchasing 4.3 Million Shares ↗
Harel Bets Big on Teva Pharmaceutical by Purchasing 4.3 Million Shares 
Via The Motley Fool
News headline image
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures ↗
SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza III Ventures. 
Via Benzinga
News headline image
Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2026 ↗
Druckenmiller is considered one of the best investors of all time. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs ↗
The Trump administration backs off plans to impose tariffs on generic drugs after internal debate over price impacts and supply concerns. 
Via Benzinga
Topics Government World Trade
News headline image
SciSparc And AutoMax Call Off Merger ↗
SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation. 
Via Benzinga
News headline image
Billionaire Stanley Druckenmiller Sold His Fund's Stakes in Nvidia and Palantir, and Has Piled Into These 2 Phenomenal Stocks for 4 Straight Quarters ↗
Duquesne Family Office's billionaire boss bid adieu to Wall Street's hottest AI stocks in favor of another trillion-dollar company and a long-awaited turnaround story in the healthcare sector. 
Via The Motley Fool
Topics Artificial Intelligence Supply Chain
News headline image
Is Teva Pharmaceutical Indus Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
Trump Administration To Unveil Tylenol-Autism Review, Tout This Drug As Potential Treatment: Report ↗
Trump administration to announce concerns about Tylenol use in pregnancy and potential treatment for autism, in line with President's priority. 
Via Benzinga
Topics Government
News headline image
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
Are the Dow's biggest yields a bargain or a warning sign? Here's how the top payouts stack up, and what that could mean for income investors. 
Via The Motley Fool
Topics Stocks
News headline image
US-India Trade War Escalates: New Tariffs Spark Inflation Fears and Corporate Profit Warnings
The global trade landscape has once again been rattled as the United States officially implemented sweeping new tariffs on a significant portion of imports from India. Effective August 27, 2025, these... 
Via MarketMinute
Topics Economy Government Supply Chain
News headline image
Teva Launches Generic GLP-1 Weight Loss Drug With FDA Nod For Saxenda ↗
Teva launches the first U.S. generic version of Saxenda for weight loss after FDA approval, expanding its portfolio with a key GLP-1 therapy. 
Via Benzinga
News headline image
FDA Approves First-Ever Generic Weight-Loss Drug In A Blow To Novo Nordisk ↗
Teva Pharmaceutical is joining compounders, knocking off one of Novo Nordisk's weight-loss drugs. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.